Immunologic response to first booster vaccination in dogs treated with zenrelia™ (ilunocitinib tablets) at up to three times the recommended therapeutic dose compared to untreated controls

Abstract Background This prospective, non-inferiority study was designed to evaluate the serologic response to booster vaccination in dogs previously vaccinated according to standard of care practice and treated for 56 days with up to 3X the recommended label dose of ilunocitinib. Vaccination occurr...

Full description

Saved in:
Bibliographic Details
Main Authors: Genevieve M. Fent, Jay Jacela, Rodrigo Plazola-Ortiz, Jeremiah Olps, Erin E. McCandless, Céline E. Toutain, Sandra O’Kelley, Stephen King
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Veterinary Research
Subjects:
Online Access:https://doi.org/10.1186/s12917-025-04929-z
Tags: Add Tag
No Tags, Be the first to tag this record!